Weight loss drugmaker Novo Nordisk will cut the list prices of Ozempic and Wegovy by up to 50% beginning in 2027, the company announced on Tuesday. Wegovy currently carries a list price of $1,349 per ...

Battling to regain its market share over rival Eli Lilly, Novo Nordisk announced Tuesday that it will reduce the list prices of its popular weight loss drug Wegovy and diabetes drugs Ozempic and ...

Property Reach reports home prices in Florida, Colorado, California, Arizona, and Texas are declining in 2026, providing buyers with new opportunities.

HomeLight reports eight spring home-selling tips that can enhance sale prices through effective pricing, timing, and ...

A Colonial home in Weston spanning 8,000 square feet with a carriage house has sold for $8.1 million, the highest in ...

Novo Nordisk on Tuesday announced plans to cut the list price of its popular diabetes and weight-loss drugs Ozempic and Wegovy by as much as 50% in the U.S. next year. The Danish drugmaker indicated ...

Novo Nordisk to cut U.S. list prices of Ozempic by 35% Price cuts coincide with new Medicare prices under Inflation Reduction Act List price changes do not impact self-pay prices Feb 24 (Reuters) - ...

Novo Nordisk on Tuesday said it plans to slash the monthly list prices of its popular obesity and diabetes drugs in the U.S. by up to 50% starting in 2027. The move aims to make the treatments more ...

Novo Nordisk on Tuesday announced plans to cut the list price of its popular diabetes and weight-loss drugs Ozempic and Wegovy by as much as 50% in the U.S. next year. The Danish drugmaker indicated ...

Novo Nordisk to slash Wegovy, Ozempic list prices Board certified rheumatologist Dr. Mahsa Tehrani discusses Novo Nordisk's decision to dramatically cut the U.S. list prices for its popular diabetes ...

Amid efforts on several fronts to improve the affordability of its GLP-1 medications for diabetes and obesity, Novo Nordisk is taking a new approach by aiming straight for semaglutide’s list price.

(CNN) — Battling to regain its market share over rival Eli Lilly, Novo Nordisk announced Tuesday that it will reduce the list prices of its popular weight loss drug Wegovy and diabetes drugs Ozempic ...